Cultured embryonic retina systems as a model for the study of underlying mechanisms of Toxoplasma gondii infection

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 8, 2004, Pages 2813-2821

  Moraes, Antonio M M ^a   Pessôa, Cristiano N ^a   Vommaro, Rossiane C ^a   De Souza, Wanderley ^a   De Mello, Fernando G ^a   Hokoç, Jan Nora ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE DECARBOXYLASE; CARBON DIOXIDE; ORNITHINE DECARBOXYLASE; THYMIDINE; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBON DIOXIDE MEASUREMENT; CELL CULTURE; CHICKEN; CHORIORETINOPATHY; CONTROLLED STUDY; EXPLANT; HIGH RISK POPULATION; MOUSE; NONHUMAN; POLYAMINE SYNTHESIS; PRIORITY JOURNAL; RETINA; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; CARBOXY-LYASES; CELLS, CULTURED; CHICK EMBRYO; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; IMMUNOENZYME TECHNIQUES; MICE; ORNITHINE DECARBOXYLASE; POLYAMINES; RETINA; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; TOXOPLASMOSIS, CONGENITAL; TOXOPLASMOSIS, OCULAR;

EID: 3242889637     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0177     Document Type: Article

References (80)

1. Dubey JP, Beattie CP. Toxoplasmosis of Animals and Man. Boca Raton, FL: CRC Press; 1988:1-40.
2. Holliman, RE. Toxoplasmosis, behaviour and personality. J Infect. 1997;35:105-110.
3. Remington JS. Toxoplasmosis in the adult. Bull NY Acad Med. 1974;50:211-227.
4. Alford CJ, Stagno S, Reynolds DW. Congenital toxoplasmosis: clinical, laboratory, and therapeutic considerations, with special reference to subclinical disease. Bull NY Acad Med. 1974;50:160-181.
5. Remington JS, McLeod R, Desmonts G. Toxoplasmosis. In: Remington J, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. 4th ed. Philadelphia: WB Saunders; 1995:140-267.
6. Luft BJ, Remington JS. AIDS commentary: toxoplasmic encephalitis. J Infect Dis. 1988;157:1-6.
7. Oksenhendler E, Cadranel J, Sarfati C. Toxoplasma gondii pneumonia in patients with the acquired immunodeficiency syndrome. Am J Med. 1990;88:5-18.
8. Strittmatter C, Lang W, Wiestler OD, Kleihues P, The changing pattern of human immunodeficiency virus-associated cerebral toxoplasmosis: a study of 46 postmortem cases. Acta Neuropathol (Berl). 1992;83:475-481.
9. Glasner PD, Silveira C, Kruszon-Moran D, et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol. 1992;114:136-144.
10. Pavesio CE, Lightman S. Toxoplasma gondii and ocular toxoplasmosis: pathogenesis. Br J Ophthalmol. 1996;80:1099-1107.
11. Holland GN. Ocular toxoplasmosis: a global reassessment. Part I. Epidemiology and course of disease. Am J Ophthalmol. 2003;136:973-988.
12. Holland GN. Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am J Ophthalmol. 2004;137:1-17.
13. Perkins ES. Ocular toxoplasmosis. Br J Ophthalmol. 1973;57:1-17.
14. Mets MB, Holfels E, Boyer KM, et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol. 1997;123:1-16.
15. Mansur H, Jones, TC, Lempert JA. Outbreak of toxoplasmosis in a family and documentation of acquired retinochoroiditis. Am J Med. 1978;64:396-402.
16. Michelson JB, Shields JA, Mcdonald PR. Retinitis secondary to acquired systemic toxoplasmosis with isolation of the parasite. Am J Ophthalmol. 1978;86:548-552.
17. Gump DW, Holden, RA. Acquired chorioretinitis due to toxoplasmosis. Am Intern Med. 1979;90:58-60.
18. Sheagren JN, Lunde MN, Simon, HB. Chronic lymphadenopathic toxoplasmosis: a case with marked hyperglobulinemia and impaired delayed hypersensitivity responses during active infection. Am J Med. 1976;60:300-305.
19. Montoya JC, Remington JS. Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis. 1996;23:277-282.
20. Bosch-Driessen EH, Rothova A. Recurrent ocular disease in postnatally acquired toxoplasmosis. Am J Ophthalmol. 1999;128:421-425.
21. Holland GN, Muccioli C, Silveira C, Weisz JM, Belfort R, O'Connor GR. Intraocular inflammatory reactions without focal necrotizing retinochoroiditis in patients with acquired systemic toxoplasmosis. Am J Ophthalmol. 1999;128:413-420.
22. Silveira C, Belfort R, Muccioli C, Abreu, MT, Martins, MC, Victora C. A follow-up study of Toxoplasma gondii infection in southern Brazil. Am J Ophthalmol. 2001;131:351-354.
23. Burnett AJ, Shortt SG, Isaac-Renton J, King A, Werker D, Bowie WR. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology. 1998;105:1032-1037.
24. Rothova A. Ocular involvement in toxoplasmosis. Br J Ophthalmol. 1993;77:371-377.
25. Pavesio CEN, Chiappino ML, Gormley P, Setzer PY, Nichols BA. Acquired retinochoroiditis in hamsters inoculated with ME 49 strain Toxoplasma. Invest Ophthalmol Vis Sci. 1995;36:2166-2175.
26. Garweg JG, Kuenzli H, Boehnke M. Experimental ocular toxoplasmosis in naïve and primed rabbits. Ophthalmologica. 1998;212:136-141.
27. Skorick DN, Chiappino ML, Nichols BA. Invasion of the guinea pig conjunctiva by T. gondii. Invest Ophthalmol Vis Sci. 1988;29:1871-1880.
28. Webb RM, Tabbara KF, O'Connor GR. Retinal vasculitis in ocular toxoplasmosis in nonhuman primates. Retina. 1984;4:182-188.
29. Gazzinelli RT, Brezin A, Li Q, Nussenblatt RB, Chan CC. Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-α and IFN-γ. Exp Parasitol. 1994;78:217-229.
30. Beverley JK, Beattie CP, Fry BA. Experimental toxoplasmosis of the uveal tract. Br J Ophthalmol. 1954;38:489-496.
31. Davidson MG, Lappin MR, English RV, Tompkins MB. A feline model of ocular toxoplasmosis. Invest Ophthalmol Vis Sci. 1993;34:3653-3660.
32. Culbertson WW, Tabbara KF, O'Connor GR. Experimental ocular toxoplasmosis in primates. Arch Ophthalmol. 1982;100:321-323.
33. Holland GH, O'Connor GR, Diaz RF, Minasi P, Wara WM. Ocular toxoplasmosis in immunosuppressed nonhuman primates. Invest Ophthalmol Vis Sci. 1988;29:835-842.
34. Hu MS, Schwartzman JD, Lepage AC, Khan IA, Kasper LH. Experimental ocular toxoplasmosis induced in naive and preinfected mice by intracameral inoculation. Ocul Immunol Inflamm. 1999;7:17-26.
35. Cowen D, Wolf A. Experimental congenital toxoplasmosis, I: the vagina as a portal of entry of Toxoplasma in the mouse. J Exp Med. 1950;92:393-402.
36. Hutchison WM, Hay J, Lee WR, Siim JC. A study of cataract in murine congenital toxoplasmosis. Ann Trop Med Parasitol. 1982;76:53-70.
37. Graham DI, Hay J, Hutchison WM, Siim JC. Encephalitis in mice with congenital ocular toxoplasmosis. J Pathol. 1984;142:265-277.
38. Sims TA, Hay J, Talbot IC. Host-parasite relationship in the brains of mice with congenital toxoplasmosis. J Pathol. 1988;156:255-261.
39. Roberts CW, Alexander J. Studies on a murine model of congenital toxoplasmosis: vertical disease transmission only occurs in BALB/c mice infected for the first time during pregnancy. Parasitology. 1992;104:19-23.
40. Ferro EAV, Bevilacqua E, Favoreto-Junior S, Silva DAO, Mortara RA, Mineo JR. Calomys callosus (Rodentia Cricetidae) trophoblast cells as host cells to Toxoplasma gondii in early pregnancy. Parasitol Res. 1999;85:647-654.
41. Halonen SK, Lyman WD, Chiu FC. Growth and development of Toxoplasma gondii in human neurons and astrocytes. J Neuropathol Exp Neurol. 1996;55:1150-1156.
42. Fischer HG, Nitzgen B, Reichmann G, Gross U, Hadding U. Host cells of Toxoplasma gondii encystation in infected primary culture from mouse brain. Parasitol Res. 1997;83:637-641.
43. Creuzet C, Robert F, Roisin MP, et al. Neurons in primary culture are less efficiently infected by Toxoplasma gondii than glial cells. Parasitol Res. 1998;84:25-30.
44. Kurz B, Bockeler W, Buse E. In vitro-model for Toxoplasma gondii invasion into neuroepithelial cells. Anat Anz. 1998;180:299-305.
45. Rozenfeld C, Martinez R, Figueiredo RT, et al. Soluble factors released by Toxoplasma gondii-infected astrocytes down-modulate nitric oxide production by gamma interferon-activated microglia and prevent neuronal degeneration. Infect Immun. 2003;71:2047-2057.
46. Cohen S. A Guide to the Polyamines. Oxford, UK: Oxford Univ. Press; 1998.
47. Igarashi K, Kashiwagi K. Polyamines: mysterious modulators of cellular functions. Biochem Biophys Res Commun. 2000;271:559-564.
48. Seabra SH, DaMatta RA, De Mello FG, De Souza W. Toxoplasma gondii does not require high levels of polyamines to develop inside macrophages. J Parasitol. In press.
49. De Mello FG, Bachrach U, Nirenberg M. Ornithine and glutamic acid decarboxylase activities in the developing chick retina. J Neurochem. 1976;27:847-851.
50. Hamburger V, Hamilton HL. A series of normal stages in the development of the chick embryo. J Morphol. 1951;88:49-92.
51. Wu WH, Morris DR. Biosynthetic arginine decarboxylase from Escherichia coli: purification and properties. J Biol Chem. 1973;248:1687-1695.
52. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
53. Yamasaki EN, Barbosa VD, De Mello FG, Hokoc JN. GABAergic system in the developing mammalian retina: dual sources of GABA at early stages of postnatal development. Int J Dev Neurosci. 1999;17:201-213.
54. Luder CG, Giraldo-Velasquez M, Sendtner M, Gross U. Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation. Exp Parasitol. 1999;93:23-32.
55. Majumder S, Wirth JJ, Bitonti AJ, McCann PP, Kierszenbaum F. Biochemical evidence for the presence of arginine decarboxylase activity in Trypanosoma cruzi. J Parasitol. 1992;78:371-374.
56. Le Quesne SA, Fairlamb AH. Regulation of a high-affinity diamine transport system in Trypanosoma cruzi epimastigotes. Biochem J. 1996;316:481-486.
57. Carrillo C, Cejas S, Gonzalez NS, Algranati ID. Trypanosoma cruzi epimastigotes lack ornithine decarboxylase but can express a foreign gene encoding this enzyme. FEBS Lett. 1999;454:192-196.
58. Freire-de-Lima CG, Nascimento DO, Soares MB, et al. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature. 2000;403:199-203.
59. de Mello MC, Ventura AL, Paes de Carvalho R, Klein WL, de Mello FG. Regulation of dopamine- and adenosine-dependent adenylate cyclase systems of chicken embryo retina cells in culture. Proc Natl Acad Sci USA. 1982;79:5708-5712.
60. De Mello FG. GABA-mediated control of glutamate decarboxylase (GAD) in cell aggregate culture of chick embryo retina. Brain Res. 1984;316:7-13.
61. Linser P, Moscona AA. Induction of glutamine synthetase in embryonic neural retina: localization in Muller fibers and dependence on cell interactions. Proc Natl Acad Sci USA. 1979;76:6476-6480.
62. Seiler N, Heby O. Regulation of cellular polyamines in mammals. Acta Biochim Biophys Hung. 1988;23:1-35.
63. Heby O, Persson L. Molecular genetics of polyamine synthesis in eukaryotic cells. Trends Biochem Sci. 1990;15:153-158.
64. Galea E, Regunathan S, Eliopoulos V, Feinstein DL, Reis DJ. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem J. 1996;316:247-249.
65. Abe K, Abe Y, Saito H. Agmatine suppresses nitric oxide production in microglia. Brain Res. 2000;872:141-148.
66. Adams LB, Hibbs JB Jr, Taintor RR, Krahenbuhl JL. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii: role for synthesis of inorganic nitrogen oxides from L-arginine. J Immunol. 1990;144:2725-2729.
67. Moscona AA. Formation of lentoids by dissociated retinal cells of the chick embryo. Science. 1957;125:598-599.
68. Moscona AA. Patterns and mechanisms of tissue reconstruction from dissociated cells. In: Rudnick D, ed. Developing Systems and Their Control. New York: Ronald Press; 1960:45-70.
69. Moscona AA. Rotation-mediated histogenetic reaggregation of dissociated cells: a quantifiable approach to cell interactions in vitro. Exp Cell Res. 1961;22:455-475.
70. Linser P, Moscona AA. Carbonic anhydrase C in the neural retina: transition from generalized to glia-specific cell localization during embryonic development. Proc Natl Acad Sci USA. 1981;78:7190-7194.
71. Linser P, Moscona AA. Induction of glutamine synthetase in embryonic neural retina: its suppression by the gliatoxic agent alpha-aminoadipic acid. Brain Res. 1981;227:103-119.
72. Martins AR, Izumi C, Pretel HS, De Mello FG. Ontogenesis of prolyl endopeptidase in the chick retina. Neurosci Lett. 1987;80:89-94.
73. Nunes-Mamede ML, De Mello FG, Martins AR. In ovo and in culture development of chick retinal angiotensin converting enzyme. Neurosci Lett. 1990;109:174-179.
74. Layer PG, Alber R, Mansky P, Vollmer G, Willbold E. Regeneration of a chimeric retina from single cells in vitro: cell-lineage-dependent formation of radial cell columns by segregated chick and quail cells. Cell Tissue Res. 1990;259:187-198.
75. De Mello FG, Hokoç JN, Ventura AL, Gardino PF. Glutamic acid decarboxylase of embryonic avian retina cells in culture: regulation by gamma-aminobutyric acid (GABA). Cell Mol Neurobiol. 1991;11:485-496.
76. Do Nascimento JL, Hokoc JN, de Mello MC, de Mello FG. Neurotransmitter release in aggregate cultures of chick embryo retina cells. Rev Bras Biol. 1996;1:135-143.
77. Willbold E, Rothermel A, Tomlinson S, Layer PG. Muller glia cells reorganize reaggregating chicken retinal cells into correctly laminated in vitro retinae. Glia. 2000;29:45-57.
78. Blasina MF, Faria AC, Gardino PF, et al. Evidence for a noncholinergic function of acetylcholinesterase during development of chicken retina as shown by fasciculin. Cell Tissue Res. 2000;299:173-184.
79. Layer PG, Robitzki A, Rothermel A, Willbold E. Of layers and spheres: the reaggregate approach in tissue engineering. Trends Neurosci. 2002;25:131-134.
80. De Almeida OM, Gardino PF, Loureiro dos Santos NE, et al. Opposite roles of GABA and excitatory amino acids on the control of GAD expression in cultured retina cells. Brain Res. 2002;925:89-99.